# Per Odin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/per-odin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,537 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 65 |
| i10-index | 199 |
| Last Known Institution | Lund University |
| OpenAlex ID | https://openalex.org/A5009097001 |
| ORCID iD | https://orcid.org/0000-0002-0756-7478 |
| Works | 361 |

## Researcher papers

- [International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study](https://scholariq.org/papers/international-multicenter-pilot-study-of-the-first-comprehensive-self-completed/)
- [The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study](https://scholariq.org/papers/the-metric-properties-of-a-novel-non-motor-symptoms-scale-for-parkinson-s/)
- [Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study](https://scholariq.org/papers/continuous-intrajejunal-infusion-of-levodopa-carbidopa-intestinal-gel-for/)
- [Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients](https://scholariq.org/papers/prevalence-of-nonmotor-symptoms-in-parkinson-s-disease-in-an-international/)
- [Parkinson’s disease: The non-motor issues](https://scholariq.org/papers/parkinson-s-disease-the-non-motor-issues/)
- [Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals](https://scholariq.org/papers/levodopa-dose-equivalency-in-parkinson-s-disease-updated-systematic-review-and/)
- [Summary of the recommendations of the <scp>EFNS</scp>/<scp>MDS</scp>‐<scp>ES</scp> review on therapeutic management of <scp>P</scp>arkinson's disease](https://scholariq.org/papers/summary-of-the-recommendations-of-the-scp-efns-scp-scp-mds-scp-scp-es-scp-review/)
- [Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach](https://scholariq.org/papers/developing-consensus-among-movement-disorder-specialists-on-clinical-indicators/)
- [Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/efficacy-of-rotigotine-for-treatment-of-moderate-to-severe-restless-legs/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Restless Legs Syndrome Research](https://scholariq.org/topics/restless-legs-syndrome-research/)
- [Parkinson's Disease and Spinal Disorders](https://scholariq.org/topics/parkinson-s-disease-and-spinal-disorders/)
- [Balance, Gait, and Falls Prevention](https://scholariq.org/topics/balance-gait-and-falls-prevention/)

## Researcher university

- [Lund University](https://scholariq.org/institutions/lund-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.